Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 4
1995 1
1997 2
1998 1
1999 1
2002 4
2003 5
2004 3
2006 5
2007 5
2008 8
2009 10
2010 8
2011 9
2012 10
2013 1
2014 4
2015 3
2016 4
2017 3
2018 4
2019 4
2020 5
2021 13
2022 9
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Teprotumumab for Thyroid-Associated Ophthalmopathy.
Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS. Smith TJ, et al. Among authors: douglas rs. N Engl J Med. 2017 May 4;376(18):1748-1761. doi: 10.1056/NEJMoa1614949. N Engl J Med. 2017. PMID: 28467880 Free PMC article. Clinical Trial.
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ. Douglas RS, et al. N Engl J Med. 2020 Jan 23;382(4):341-352. doi: 10.1056/NEJMoa1910434. N Engl J Med. 2020. PMID: 31971679 Clinical Trial.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ. Douglas RS, et al. Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21. Ophthalmology. 2022. PMID: 34688699 Free article. Clinical Trial.
Reply.
Shah SA, Amarikwa L, Sears CM, Clauss KD, Rajjoub RD, Kang JY, Tamhankar MA, Briceño CA, Harrison AR, Cockerham KP, Wester ST, Douglas RS, Dosiou C, Kossler AL. Shah SA, et al. Among authors: douglas rs. Ophthalmology. 2024 Feb 12:S0161-6420(24)00003-4. doi: 10.1016/j.ophtha.2024.01.003. Online ahead of print. Ophthalmology. 2024. PMID: 38349298 No abstract available.
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.
Kahaly GJ, Dolman PJ, Wolf J, Giers BC, Elflein HM, Jain AP, Srinivasan A, Hadjiiski L, Jordan D, Bradley EA, Stan MN, Eckstein A, Pitz S, Vorländer C, Wester ST, Nguyen J, Tucker N, Sales-Sanz M, Feldon SE, Nelson CC, Hardy I, Abia-Serrano M, Tedeschi P, Janes JM, Xu J, Vue P, Macias WL, Douglas RS. Kahaly GJ, et al. Among authors: douglas rs. J Clin Endocrinol Metab. 2023 Nov 17;108(12):3122-3134. doi: 10.1210/clinem/dgad381. J Clin Endocrinol Metab. 2023. PMID: 37390454 Free PMC article. Clinical Trial.
Pediatric hyperthyroidism and thyroid eye disease management.
Li J, Austin J, Douglas RS, Nallasamy S. Li J, et al. Among authors: douglas rs. J AAPOS. 2023 Jun;27(3):123-128. doi: 10.1016/j.jaapos.2023.02.008. Epub 2023 May 12. J AAPOS. 2023. PMID: 37182650 Review. No abstract available.
The Spectrum of Aesthetic Canthal Suspension.
Wang Y, Holds JB, Douglas RS, Massry GG. Wang Y, et al. Among authors: douglas rs. Facial Plast Surg Clin North Am. 2021 May;29(2):275-289. doi: 10.1016/j.fsc.2021.01.005. Epub 2021 Apr 24. Facial Plast Surg Clin North Am. 2021. PMID: 33906760 Review.
Changing the face of thyroid eye disease.
Ugradar S, Goldberg RA, Douglas RS. Ugradar S, et al. Among authors: douglas rs. Eye (Lond). 2023 Feb;37(2):197-199. doi: 10.1038/s41433-022-02186-0. Epub 2022 Jul 26. Eye (Lond). 2023. PMID: 35882983 Free PMC article. No abstract available.
The Prominent Eye-What to Watch Out For.
Landsberger H, Wang Y, Douglas RS. Landsberger H, et al. Among authors: douglas rs. Facial Plast Surg Clin North Am. 2021 May;29(2):311-321. doi: 10.1016/j.fsc.2021.02.004. Epub 2021 Apr 24. Facial Plast Surg Clin North Am. 2021. PMID: 33906763 Review.
121 results